anti-HER2 antibody (Abclon)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameanti-HER2 antibody (Abclon)

Drug Alias NameKDDF-201408-02

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonists

TargetsReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsStomach Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAbclon Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAbclon Inc

Active IndicationsN/A

Inactive IndicationsStomach Neoplasms

ATC CodeN/A